Earnings Feed
Start Free
Home/Filings/4/0000899243-18-025660
4//SEC Filing

KOSKI FAMILY LP 4

Accession 0000899243-18-025660

CIK 0001174940other
View on SEC.govCompany Profile

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 4:07 PM ET

Size

15.9 KB

Accession

0000899243-18-025660

Insider Transaction Report

Form 4
Period: 2018-09-27
ORAGENICS INCOGEN
KOSKI CHRISTINE L
Director10% Owner
Transactions
  • Award

    Non-Employee Director Option (Right to Buy)

    2018-09-27+125,000→ 125,000 total
    Exercise: $0.73From: 2018-09-27Exp: 2028-09-27→ Common Stock (125,000 underlying)
Holdings

  • Common Stock

    157,254

  • Common Stock

    91,967

  • Common Stock

    (indirect: By Koski Management, Inc.)
    2,800

  • Common Stock

    1,286,483

  • Common Stock

    277,839

  • Common Stock

    (indirect: By Trust)
    53,086
KOSKI BEVERLY
10% Owner
Transactions
  • Award

    Non-Employee Director Option (Right to Buy)

    2018-09-27+125,000→ 125,000 total
    Exercise: $0.73From: 2018-09-27Exp: 2028-09-27→ Common Stock (125,000 underlying)
Holdings

  • Common Stock

    157,254

  • Common Stock

    91,967

  • Common Stock

    277,839

  • Common Stock

    1,286,483

  • Common Stock

    (indirect: By Trust)
    53,086

  • Common Stock

    (indirect: By Koski Management, Inc.)
    2,800
KOSKI FAMILY LP
10% Owner
Transactions
  • Award

    Non-Employee Director Option (Right to Buy)

    2018-09-27+125,000→ 125,000 total
    Exercise: $0.73From: 2018-09-27Exp: 2028-09-27→ Common Stock (125,000 underlying)
Holdings

  • Common Stock

    1,286,483

  • Common Stock

    277,839

  • Common Stock

    (indirect: By Koski Management, Inc.)
    2,800

  • Common Stock

    (indirect: By Trust)
    53,086

  • Common Stock

    157,254

  • Common Stock

    91,967
KOSKI THOMAS L
10% Owner
Transactions
  • Award

    Non-Employee Director Option (Right to Buy)

    2018-09-27+125,000→ 125,000 total
    Exercise: $0.73From: 2018-09-27Exp: 2028-09-27→ Common Stock (125,000 underlying)
Holdings

  • Common Stock

    (indirect: By Koski Management, Inc.)
    2,800

  • Common Stock

    277,839

  • Common Stock

    1,286,483

  • Common Stock

    157,254

  • Common Stock

    91,967

  • Common Stock

    (indirect: By Trust)
    53,086
KOSKI ROBERT C
Director10% Owner
Transactions
  • Award

    Non-Employee Director Option (Right to Buy)

    2018-09-27+125,000→ 125,000 total
    Exercise: $0.73From: 2018-09-27Exp: 2028-09-27→ Common Stock (125,000 underlying)
Holdings

  • Common Stock

    157,254

  • Common Stock

    (indirect: By Trust)
    53,086

  • Common Stock

    277,839

  • Common Stock

    91,967

  • Common Stock

    1,286,483

  • Common Stock

    (indirect: By Koski Management, Inc.)
    2,800
Footnotes (8)
  • [F1]Shares owned directly by Koski Family Limited Partnership ("KFLP"). Shares owned indirectly by the KFLP general partners: Koski Management, Inc. (solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
  • [F2]Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
  • [F3]Shares owned directly by Christine L. Koski.
  • [F4]Shares owned directly by Robert C. Koski, a director of the Company.
  • [F5]Shares owned directly by Thomas L. Koski.
  • [F6]Shares owned indirectly by Beverly Koski (through Koski Management, Inc.).
  • [F7]Shares owned by trusts of which Mr. Robert C. Koski is sole trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (10,760 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (10,760 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (10,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (10,760 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (10,806 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.
  • [F8]Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended in connection with service to the Company as a director. The options vest immediately. The option exercise price is the closing price on the date of the grant, September 27, 2018.

Documents

1 file

Issuer

ORAGENICS INC

CIK 0001174940

→
Entity typeother

Related Parties

1
  • filerCIK 0001234879

Filing Metadata

Form type
4
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:07 PM ET
Size
15.9 KB
View on SEC.gov